Member access

4-Traders Homepage  >  Shares  >  London Stock Exchange  >  PuriCore plc    PURI   GB00B3XBCR18

PURICORE PLC (PURI)

2
Delayed Quote. Delayed London Stock Exchange - 01/30 11:35:10 am
32 GBp   --.--%
01/09 PURICORE : Holding(s) in Company
2014 PURICORE : Mill Residential Floats On AIM, PuriCore Moves From Main ..
2014 PURICORE : commences trading on AIM
 SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed London Stock Exchange
01/26/2015 01/27/2015 01/28/2015 01/29/2015 01/30/2015 Date
32(c) 32(c) 32(c) 32(c) 32 Last
3 994 20 000 24 734 0 3 427 Volume
-0.78% 0.00% 0.00% 0.00% 0.00% Change
More quotes
Company
PuriCore Plc engages in the development and commercialization of antimicrobial solutions and complementary products.It caters to the supermarket retail and health sciences markets by offering products to supermarket retailers for use in the fresh produce department and solutions for treatment of... 
More about the company
Chart PURICORE PLC
Duration : Period :
PuriCore plc Technical Analysis Chart | PURI | GB00B3XBCR18 | 4-Traders
Full-screen chart
Financials ( GBP)
Sales 2014 31,7 M
EBIT 2014 -
Net income 2014 -
Debt 2014 -
Yield 2014 -
Sales 2015 38,3 M
EBIT 2015 -
Net income 2015 -
Debt 2015 -
Yield 2015 -
PER 2014 -
PER 2015
Capi. / Sales 2014 0,51x
Capi. / Sales 2015 0,42x
Capitalization 16,1 M
More Financials
Latest news on PURICORE PLC
01/09 PURICORE : Holding(s) in Company
2014 PURICORE : Mill Residential Floats On AIM, PuriCore Moves From Main Market (ALLI..
2014 PURICORE : commences trading on AIM
2014 PURICORE : commences trading on AIM
2014 PURICORE : Preliminary Decisions Arising From The On-Going Strategic And Operati..
2014 PURICORE : To Invest Disposal Cash Rather Than Return To Shareholders
2014 PURICORE : Strategic and Operational Review Update
2014 PURICORE : Result of General Meeting
More news
Sector news Biotechnology & Medical Research - NEC
06:14a PHARMACYCLICS : Johnson & Johnson: U.S. FDA Approves IMBRUVICA (ibrutinib) for t..
01/29DJValeant to Buy Prostate-Cancer Drug From Dendreon
01/29DJValeant in Deal to Buy Prostate-Cancer Drug Provenge From Dendreon
Plus d'actualités du secteur Biotechnology & Medical Research - NEC


Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Technical analysis
Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF